Delivery Order HHSN261201700007I-75N91022F00002

Award Date 7/22/22
Potential Completion Date 10/21/22
Potential Value $44K
Ultimate Awardee
Not listed
PSC Category
6810 - Chemicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Alachua, FL 32615, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order, valued at $10,900, was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Pointcare Systems Inc. R&D Division, doing business as Chirosolve, for the synthesis of tert-butyl (R)-3-(5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)piperidine-1-carboxylate in a 75 gram quantity with over 95% purity. The solicitation sought synthesis and delivery of the specified intermediate...
<p>This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Chiralix B.V., a for-profit organization, for the custom synthesis of a cyclic depsipeptide titled &quot;CLOSELY ASSOCIATED&quot;. The award has a ceiling value of $19,160.00 and an ultimate completion date of July 31, 2015. The contract was awarded on March 4, 2015 and does not have a set-aside designation.</p>
This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED for the acquisition of 15 grams of PT-2977 (CAS: 1672668-24-4) with a chemical purity exceeding 95% and enantiopurity exceeding 95%. The contract has a ceiling value of $24,800.00 and a completion date of July 8, 2020. This award is not associated with any set-aside program. Wuxi...
<p>The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. a $189 firm fixed price delivery order for 100 tablets of 2.5 mg methotrexate. The place of performance is Park Ridge, Illinois and all work is to be completed by August 8, 2023. This contract has no set-aside designation and is a direct award to the prime contractor for the specified pharmaceutical products.</p>
The Defense Logistics Agency (DOD) awarded a $378,000 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the procurement of 100 units of 2.5 mg methotrexate tablets. DMS Pharmaceutical Group Inc. will fulfill the order from its facility located in Park Ridge, Illinois. The delivery order was issued against an existing DOD contract vehicle and has a period of performance spanning August 7-8, 2023. No subcontractors or set aside designations were identified. The DLA supports...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $297.60 to Amerisourcebergen Drug Corp for the supply of 100 units of 2.5 mg methotrexate tablets. As the prime contractor, Amerisourcebergen Drug Corp will fulfill the order from its facility located in Conshohocken, Pennsylvania. The single day period of performance from July 5-6, 2023 indicates this was likely an urgent order placed under the Agency's Prime Vendor Next contract vehicle to support the medical...
The Defense Logistics Agency awarded a $9,910 delivery order to Amerisourcebergen Drug Corporation for methotrexate in 1 gram/40 ml vials. The firm fixed price order is for 40 ml vials of the chemotherapy drug to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania and will be completed by June 23, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for methotrexate is consistent with the Defense Logistics Agency's...
The Defense Logistics Agency awarded a $69,370 delivery order to Amerisourcebergen Drug Corporation for methotrexate in 1 gram/40 ml vials. The firm fixed price order is for 40 ml vials of the chemotherapy drug to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania and will be completed by July 26, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for methotrexate will support the DLA's mission to provide...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $18,880 to Amerisourcebergen Drug Corporation for the supply of 4561986295 units of methotrexate at 50 mg/2 ml per vial with 2 ml volume. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania over a one day period from August 29, 2023 through August 30, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for the...
The Defense Logistics Agency awarded a $317 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 tablets of 2.5 mg methotrexate. The prime contractor will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill DLA requirements. No major subcontractors or set aside designations were identified. This order was placed under an existing DLA pharmaceuticals contract vehicle to support the Agency's medical supply needs.
  • HHSN261201700007I
    Indefinite Delivery Contract
  • HHSN261201700007I-75N91022F00002
    Delivery Order

THE NON-GMP SYNTHESIS OF 100 GRAMS OF (R)-N-(6-CHLORO-4-((1-PHENYLETHYL)AMINO)PYRIDO[3,4-D]PYRIMIDIN-5-YL)METHANE-SULFONAMIDE (MTX-531)

Posted 7/21/22, 12:00 AM